SAVE THE DATE !

FEBRUARY 23, 2017

TORONTO

Biomanufacturing in Canada:

Stimulating the future!

The Fondation Biotech Montréal (FBM), in collaboration with the National Research Council of Canada (NRC) and JLABS @ Toronto invite you to a workshop on the industrial and commercial potential of biomanufacturing in Canada.

  • Rich biologics pipeline in Canada
  • Biologics development value chain and biomanufacturing services
  • Roundtable discussion on market opportunities and challenges
  • Success story in Australia; an inspiring testimonial
  • Networking

Location

JLABS @ Toronto
MaRS Centre, West Tower
661 University Avenue, Suite 1300
Toronto, Ontario, Canada, M5G 0B7

Time

7:30 a.m. to 12:00 p.m.

Cost

$95.00
Coffee and pastries will be served

Keynote Speakers

BIOMANUFACTURING IN CANADA: Bernard Massie, General Manager, Human Health Therapeutics, National Research Council Canada

Bernard Massie
General Manager,
Human Health Therapeutics
National Research Council Canada

See Profile
BIOMANUFACTURING IN CANADA: David Hughes, Director, New Horizons Biotech

David Hughes
Director
New Horizons Biotech
(by Skype)

See Profile
BIOMANUFACTURING IN CANADA: Louis-Félix Binette Strategic Advisor Escouade

Maureen O’Connor
Chief Scientific Officer
Formation Biologics

See Profile
BIOMANUFACTURING IN CANADA: Louis-Félix Binette Strategic Advisor Escouade

Louis-Félix Binette
Strategic Advisor
Escouade

See Profile

Preliminary Program

7:30 a.m.

Registration and networking
Continental breakfast will be served


8:00 a.m.

Welcome
Rebecca Yu, Head of JLABS @ Toronto


8:10 a.m.

Introduction
Dr. Roman Szumski, Vice-President of Life Sciences, National Research Council of Canada


8:20 a.m.

Biomanufacturing in Australia: Case study and success story
David Hughes, Director, New Horizons Biotech (by Skype)

This presentation will highlight how Australia established its leading position in biomanufacturing, and the challenges and lessons learned along the way.


8:40 a.m.

Questions


8:50 a.m.

Biomanufacturing in Canada: An opportunity for development?
Bernard Massie, General Manager, Human Health Therapeutics, National Research Council of Canada

Canada has a rich biotech pipeline, but these products developed in Canada are being manufactured abroad. This presentation will highlight industry trends and set the table for the consultation workshop.


9:10 a.m.

Testimonial: A Canadian biotech’s experience manufacturing in Canada
Maureen O’Connor, Chief Scientific Officer, Formation Biologics


9:30 a.m.

Questions


9:40 a.m.

Introduction to the consultation workshop
Louis-Félix Binette, Strategic Advisor, Escouade Moderation

In this workshop, we will leverage the collective knowledge and experience of biotech participants to map out how Canada could best create value from biomanufacturing, identify specific opportunities, and establish next steps.


9:55 a.m.

Break and networking


10:25 a.m.

Consultation workshop
All participants – break out discussions and reconvene to share ideas


12:15 p.m.

Closing remarks and next steps
Eileen Raymond on behalf of Nicola Urbani, Member of the Board, Fondation Biotech Montreal


12:30 p.m.

End of the workshop


Register Now!

Take advantage of this unique opportunity to hear our keynote speakers and to contribute in this national effort to establish potential solutions to develop biomanufacturing in Canada.

CLICK HERE TO REGISTER

Collaborators

For the last 15 years, the main goal of Fondation Biotech Montréal (FBM) has been to promote the growth of the Canadian Life Sciences Industry in the area of Human Health. With the leadership of recognized industry members, the FBM, a non-for-profit organization, has worked hand in hand with NRC to provide a forum for technology transfer between Canadian research centres and industry by organizing different editions of the BioTransfer event in Toronto, Montréal and Boston. This success followed the previous 12 editions of the Crossroad of Biotechnology that attracted renowned international keynote speakers around the world to Montréal and gathered the whole biotech community within the walls of NRC-Royalmount, remembered as Biotechnology Research Institute (BRI).

Since 2016 and to continue in alignment with its mission, FBM is committed to promoting the development of a strong Biomanufacturing Sector in Canada in partnership with NRC – Human Health Therapeutics. This exciting undertaking needs to be developed not only by the FBM and NRC, but in collaboration with all stakeholders which will benefit from the economic impacts of manufacturing biologics in our country.

We hope that the consultation workshop on February 23rd will help identify the opportunities and challenges of biomanufacturing in Canada, and will pave the road to a bright future!

Your participation is greatly appreciated,

 

Nicola Urbani
President, Board of administrators

In Collaboration With:

For more Information

(514) 439-5538 or 1-844-285-2342
info@biomanufacturing.ca

Semaphore DigitalBiomanufacturing in Toronto – February 23rd, 2017